2.5 Post-GLP1 Use Case While no large trials directly study GLP1 tapering with Phentermine/Topiramate, clinical experience supports it because: Drug combination has a strong appetite suppressing profile It supports long-term maintenance (over 1 year) in trials like CONQUER and EQUIP The dual mechanism (appetite + craving reduction) makes it an ideal maintenance therapy 2.6 Common Side Effects from Phentermine/Topiramate (Qsymia ) Phentermine/Topiramate side effects have been well documented and are manageable for most people
You can read more on the AOD-9604 product page or the combo product page
Watch for upper abdominal pain, nausea, bloating, or fever
After eating a meal, these hormones cause neural signals that trigger feelings of fullness prematurely, which leads to reduced food intake and long term fat loss
5a), and G0/G1-phase fibroblasts of keloids and normal skins decreased from 90.78% 1.62% to 63.68% 11.16%, and from 75.47% 4.62% to 49.4% 8.95%, respectively ( p = 0.002 and p = 0.003, respectively
